These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33559024)

  • 21. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.
    Pelusi S; Cespiati A; Rametta R; Pennisi G; Mannisto V; Rosso C; Baselli G; Dongiovanni P; Fracanzani AL; Badiali S; Maggioni M; Craxi A; Fargion S; Prati D; Nobili V; Bugianesi E; Romeo S; Pihlajamaki J; Petta S; Valenti L
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2310-2319.e6. PubMed ID: 30708111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study.
    Abdelbary MS; Marzaban R; Gamal Eldeen H; Khairy M; Menesy M; Fahmy MH; Ayad AM; Mouheb BS; Yosry A
    Rev Gastroenterol Mex (Engl Ed); 2021; 86(2):125-132. PubMed ID: 33004251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Fatty Acid for Diagnosing Non-Alcoholic Steatohepatitis in Patients with Severe Obesity Undergoing Metabolic Surgery.
    Takahashi N; Sasaki A; Umemura A; Sugai T; Kakisaka K; Ishigaki Y
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.
    Auguet T; Bertran L; Binetti J; Aguilar C; Martínez S; Sabench F; Lopez-Dupla JM; Porras JA; Riesco D; Del Castillo D; Richart C
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy.
    Ma B; Sun H; Zhu B; Wang S; Du L; Wang X; Qu S
    Obes Facts; 2021; 14(1):64-71. PubMed ID: 33352578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients.
    Wu HC; Hsieh YR; Wang W; Chang CW; Chang IW; Chen CL; Chang CC; Chang CH; Kao WY; Huang SY
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway.
    Kumagai H; Sasaki A; Umemura A; Kakisaka K; Iwaya T; S Nishizuka S
    Endocr J; 2024 Feb; 71(2):139-152. PubMed ID: 38171883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
    Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
    de Brito E Silva MB; Tustumi F; de Miranda Neto AA; Dantas ACB; Santo MA; Cecconello I
    Obes Surg; 2021 Jun; 31(6):2762-2772. PubMed ID: 33846949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features.
    Sasaki A; Umemura A; Ishida K; Takahashi N; Nikai H; Nitta H; Takikawa Y; Kakisaka K; Abe T; Nishiya M; Sugai T
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis.
    Bloomer SA; Olivier AK; Bergmann OM; Mathahs MM; Broadhurst KA; Hicsasmaz H; Brown KE
    Cell Biochem Funct; 2016 Dec; 34(8):628-639. PubMed ID: 27935134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleeve Gastrectomy Reduces the Need for Liver Transplantation in Patients with Obesity and Non-Alcoholic Steatohepatitis: a Predictive Model.
    Rouhi AD; Castle RE; Hoeltzel GD; Williams NN; Dumon KR; Baimas-George M; Wachs M; Nydam TL; Choudhury RA
    Obes Surg; 2024 Apr; 34(4):1224-1231. PubMed ID: 38379059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience.
    Morris MC; Jung AD; Kim Y; Lee TC; Kaiser TE; Thompson JR; Bari K; Shah SA; Cohen RM; Schauer DP; Smith EP; Diwan TS
    Liver Transpl; 2019 Nov; 25(11):1673-1681. PubMed ID: 31518478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery.
    Weingarten TN; Swain JM; Kendrick ML; Charlton MR; Schroeder BJ; Lee RE; Narr BJ; Ribeiro TC; Schroeder DR; Sprung J
    Obes Surg; 2011 Nov; 21(11):1714-20. PubMed ID: 21948267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
    Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
    Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.